Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
{{output}}
The epidermal growth factor receptor 2 (HER2) is a tyrosine kinase overexpressed in nearly 20% to 25% of invasive breast cancers. Trastuzumab is a humanized monoclonal antibody that targets HER2. The majority of patients with metastatic breast cancer initially... ...
